Low-dose computed tomography lung cancer screening as a teachable moment for smoking cessation among African American smokers: A feasibility study

Sly, Jamilia; Miller, Sarah; Li, Yaqi; Bolutayo, Kemi; Jandorf, Lina

doi:10.1080/07347332.2018.1499693

Cited by 1 publication

(1 citation statement)

References 20 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…There is no consistent evidence of a "licence to smoke" effect, whereby a normal scan discourages quitting. Indeed, there is some research to suggest that LCS represents a "teachable moment" where participants maybe particularly receptive to smoking cessation interventions [189,[195][196][197]. Research published in abstract form from the UK has shown that quit rates of over 30% at 1 year can be achieved using opt-out, co-located, comprehensive cessation services with follow-up [183,198].…”

Section: Evidence Reviewmentioning

confidence: 99%

Developing a pan-European technical standard for a comprehensive high-quality lung cancer computed tomography screening programme: an ERS technical standard

et al. 2023

View full text Add to dashboard Cite

Screening for lung cancer with low radiation dose computed tomography (LDCT) has a strong evidence base. The European Council adopted a recommendation in November 2022 that lung cancer screening be implemented using a stepwise approach. The imperative now is to ensure that implementation follows an evidence-based process that delivers clinical and cost effectiveness. This ERS Taskforce was formed to provide a technical standard for a high-quality lung cancer screening program.MethodA collaborative group was convened to include members of multiple European societies (see below). Topics were identified during a scoping review and a systematic review of the literature was conducted. Full text was provided to members of the group for each topic. The final document was approved by all members and the ERS Scientific Advisory Committee.ResultsTen topics were identified representing key components of a screening program. The action on findings from the LDCT were not included as they are addressed by separate international guidelines (nodule management and clinical management of lung cancer) and by a linked taskforce (incidental findings). Other than smoking cessation, other interventions that are not part of the core screening process were not included (e.g.pulmonary function measurement). Fifty-three statements were produced and areas for further research identified.ConclusionThis European collaborative group has produced a technical standard that is a timely contribution to implementation of LCS. It will serve as a standard that can be used, as recommended by the European Council, to ensure a high quality and effective program.

show abstract